Esperion Therap (ESPR) Posts Q1 Loss of 51c/Share

Esperion Therap (NASDAQ: ESPR) reported Q1 EPS of ($0.51), $0.11 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Esperion Therap (ESPR) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Caterpillar (CAT) PT Raised to $1,105 at Oppenheimer
• JD.com, Inc (JD) PT Lowered to $37 at Macquarie ahead of earnings